¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Research on aging."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® aging, senescence ÇÑ±Û ³ëÈ­, ´ÄÀ½
¼³¸í   
  ³ªÀÌ ¸Ô´Â´Ù´Â Àǹ̷Π»ç¿ëµÇ±âµµ ÇÏÁö¸¸ ÀϹÝÀûÀ¸·Î´Â ¼ºÀåÀÌ ¿Ï·á, Á¤ÁöµÇ°í ±× ÀÌÈÄ¿¡ ÀϾ´Â ¸ðµç °úÁ¤À» °¡¸®Å²´Ù. ³ªÀ̸¦ ¸Ô¾î°¨¿¡ µû¶ó »ýüÀÇ ¿©·¯ °¡Áö ±â´ÉÀÌ ÀúÇϵǴµ¥, ÀϹÝÀûÀ¸·Î ¼¼Æ÷¿¡ »ö¼Ò°¡ ÃàÀûµÇ°Å³ª ¼¼Æ÷ÀÚü³ª ÇÙÀÌ ÀÛ¾ÆÁö´Â Çö»óÀÌ´Ù. °³°³ÀÇ ¼¼Æ÷ ±â´Éµµ ÀúÇϵǰí, ¼¼Æ÷ ³»¿¡ »ö¼Ò°¡ Ä§ÂøµÇ¸ç, ±â°üÀº ¾Ï°¥»öÀ» ¶í´Ù. ¶ÇÇÑ ÇǺδ ¾ã¾ÆÁö°í ÅÐÁָӴϵµ À§ÃàµÇ¸ç, ¸ð¹ßÀº »ö¼Ò¸¦ ÀÒ°í Å»¸ðµÈ´Ù. ÇöÀç ¸¹Àº ÇÐÀÚµéÀº ¼¼Æ÷³» DNA°¡ ²÷¾îÁö°Å³ª ²÷¾îÁø °æ¿ì ¼öº¹·ÂÀÌ °¨¼ÒÇϰųª, ¸é¿ª·ÂÀÌ ÀúÇÏÇϱ⠶§¹®À¸·Î º¸°í ÀÖ´Ù. ³ëÈ­°¡ ÀϾ´Â °ÍÀº ¼¼Æ÷ÀÇ Á¾·ù¿¡ µû¶ó¼­ Å©°Ô ´Ù¸¥µ¥ ½Å°æ¼¼Æ÷󷳠ž¼­ Á×À» ¶§±îÁö ¼¼Æ÷ºÐ¿­ÇÏÁö ¾Ê´Â ¼¼Æ÷´Â ³ëÈ­°¡ µÎµå·¯Áö°í °íȯÀ̳ª °ñ¼öÀÇ ¼¼Æ÷ó·³ Ç×»ó ºÐ¿­Çϴ ¼¼Æ÷´Â ³ëÈ­Çö»óÀÌ °ÅÀÇ ÀϾÁö ¾Ê´Â´Ù. ¹ßº´°ú Á×À½ÀÇ È®·üÀÌ ³ô¾ÆÁöÁö¸¸, ³ë¼è¼º º¯È­¿Í º´Àû º¯È­¿ÍÀÇ °æÁ¦´Â ¸íÈ®ÇÏÁö ¾Ê´Ù. ³ë¼è¸¦ ¾ß±âÇϴ ³ëÈ­ÀÇ º»ÁúÀû ¿øÀο¡ ´ëÇØ¼­´Â ¾ÆÁ÷ Á¤¼³ÀÌ ¾ø´Ù.
¿µ¹® VDRL(venereal disease research laboratory) ÇÑ±Û ¼ºº´ ¿¬±¸½ÇÇè½Ç
¼³¸í   
  ¸Åµ¶±ÕÀÇ reagin¿¡ ´ëÇÑ Ç×ü. ¸Åµ¶ÀÇ ¼±º°°Ë»ç·Î »ç¿ëµÇ¸ç ¸Åµ¶ Ä¡·á¿¡ ´ëÇÑ ¹ÝÀÀ ¿©ºÎ¿Í Ä¡·áÈ¿°ú ÆÇÁ¤¿¡µµ »ç¿ëµÈ´Ù. ¸Åµ¶¿Ü¿¡µµ Àü½Å¼ºÈ«¹Ý¼º³¶Ã¢, ·ù¸¶Æ¼½º°üÀý¿° µî¿¡¼­µµ ¾ç¼ºÀ¸·Î ³ªÅ¸³¯ ¼ö ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aging
    1. ³ëÈ­ 2. ³ë·ÉÈ­ 3. ³ªÀ̸ÔÀ½
  • aging process
    ³ëÈ­°úÁ¤
  • cellular aging
    ¼¼Æ÷³ëÈ­
  • programmed aging
    ¿¹Á¤³ëÈ­
  • research
    ¿¬±¸
  • research design
    ¿¬±¸°èȹ
  • research diagnostic criteria
    ¿¬±¸Áø´Ü±âÁØ
  • venereal disease research laboratory test
    ¸Åµ¶Ç÷û°Ë»ç, VDRL°Ë»ç
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aging
    ³ëÈ­, ³ªÀ̸ÔÀ½
  • aging process
    ³ëÈ­°úÁ¤
  • research
    ¿¬±¸
  • diagnostic research
    Áø´Ü¿¬±¸
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aging
    ³ëÈ­, ´ÄÀ½
  • aging process
    ³ëÈ­°úÁ¤
  • cellular aging
    ¼¼Æ÷³ëÈ­
  • programmed aging
    ¿¹Á¤³ëÈ­
  • research diagnostic criteria
    ¿¬±¸Áø´Ü±âÁØ
  • research design
    ¿¬±¸°èȹ
  • operational research
    ÀÛÀü¿¬±¸
  • research
    ¿¬±¸
  • venereal disease research laboratory test
    ¸Åµ¶Ç÷û°Ë»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aging,free radical theory
    À¯¸®±â ¼³(ë´×îÐñàã)
  • programmed aging
    °èȹµÈ¡¡³ëÈ­
  • Lipid Research Clinic
    ÁöÁú¿¬±¸Áø·á¼Ò
  • RDC, see Research Diagnostic Criteria
    ¿¬±¸Áø´Ü±âÁØ, ¿¬±¸¿ë Áø´Ü±âÁØ
  • VDRL test= venereal disease research laboratory test
    ¼ºº´¿¬±¸¼Ò½ÄÅ×½ºÆ®.
  • VDRL test= venereal disease research laboratory test
    ¼ºº´¿¬±¸¼Ò½ÄÅ×½ºÆ®.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • research diagnostic criteria(RDC)
    ¿¬±¸Áø´Ü±âÁØ
  • venereal disease research laboratory test =VDRL test
    ¼ºº´¿¬±¸¼Ò½ÄÅ×½ºÆ®.
  • venereal disease research laboratory test =VDRL test
    ¼ºº´¿¬±¸¼Ò½ÄÅ×½ºÆ®.
  • aging
    ³ëÈ­(ÒÇûù)
  • aging
    ³ëÈ­(ÖÕûù)
  • aging
    ³ëÈ­(ËÈÌ´), °¡·É(˧ËÈ).
  • aging
    ³ëÈ­, °¡·É(Ê¥ÖÆ)
  • aging patient
    °í·ÉȯÀÚ.
  • aging test
    ³ëÈ­½ÃÇè(ËÈÌ´ËàÌ´).
  • aging,free radical theory
    À¯¸®±â ¼³(ë´×îÐñàã)
  • cellular aging
    ¼¼Æ÷³ëÈ­(á¬øàÖÕûù)
  • myocardium,aging effect
    ³ëÈ­Çö»ó(ÖÕûùúÞßÚ)
  • programmed aging
    °èȹµÈ¡¡³ëÈ­
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aging
    ³ëÈ­(ÒÇûù)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aging
    ³ëÈ­, °¡·É
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AFAR American Foundation for Aging Research
AAA abdominal aortic aneurysm/aneurysmectomy; acne-associated arthritis; acquired aplastic anemia; acute...
AAHA American Academy of Hospital Attorneys; American Association of Homes for the Aging
ABS abdominal surgery; acute brain syndrome; Adaptive Behavior Scale; admitting blood sugar; adult bovin...
AOA American Osteopathic Association; Administration on Aging; Alpha Omega Alpha Honor Society; American...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
BLSA Baltimore Longitudinal Study of Aging
CSHA Canadian Study of Health and Aging
LSOA Longitudinal Study of Aging
NIA National Institute of Aging
ARCI Addiction Research Center Inventory
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • JrId: 6911
    JournalTitle: Research on aging.
    MedAbbr: Res Aging
    ISSN: 0164-0275
    ESSN:
    IsoAbbr:
    NlmId: 7908221
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • aging
    ³ëÈ­, °¡·É, ½Ãȿó¸®
    1. Áúº´ ¶Ç´Â ±âŸÀÇ Å« »ç°í µî¿¡ ÀÇÇÑ °ÍÀÌ ¾Æ´Ï¸ç ½Ã°£°æ°ú, Áï ¿¬·É Áõ°¡¿¡ µû¶ó ¼ö¹ÝµÇ´Â »ýü ±¸Á¶ÀÇ ¿Ï¸¸ÇÑ º¯È­·Î¼­ ±Ã±ØÀûÀ¸·Î´Â ¿¬·ÉÀÌ ¸¹¾ÆÁ®, Áï ´Ä¾î¼­ »ç¸Á¿¡ À̸¥´Ù. 2. °¡°ø º¯Çü ¹× ÁÖÁ¶ Æí¼®À» ¾ø¾Ö±â À§ÇÑ ¼ÒµÐ°ú ±â°èÀû ¼ºÁúÀ» ¹Ù²Ù´Â °Í.
  • aging patient
    °í·É ȯÀÚ
  • aging phenomena
    ³ë¼è Çö»ó
  • aging,free radical theory
    À¯¸®±â¼³
  • myocardium,aging effect
    ³ëÈ­ Çö»ó
  • clinical research
    ÀÓ»ó ¿¬±¸
  • pain research laboratory
    µ¿Åë ¿¬±¸¼Ò
  • preclinical research
    ÀÓ»ó Àü ¿¬±¸
  • research
    ¿¬±¸, Á¶»ç
  • The National Institute of Dental Research
    ±¹¸³ Ä¡ÀÇÇÐ ¿¬±¸¼Ò
  • VDRL : Venereal Disease Research LaboratoryÀÇ ¾àÀÚ. ¸Åµ¶±ÕÀÇ Reagin¿¡ ´ëÇÑ Ç×ü·Î, ¸Åµ¶ÀÇ ¼±º°°Ë»ç·Î »ç¿ëµÇ¸ç ¸Åµ¶ Ä¡·á¿¡ ´ëÇÑ ¹ÝÀÀ ¿©ºÎ°¡ Ä¡·á È¿°ú ÆÇÁ¤¿¡ »ç¿ëµÈ´Ù. ¸Åµ¶ ¿Ü¿¡µµ Àü½Å¼º È«¹Ý¼º ³¶Ã¢(SLE), ·ù¸¶ÅäÀÌµå °üÀý¿° µî¿¡¼­µµ ¾ç¼ºÀ¸·Î ³ªÅ¸³¯ ¼ö ÀÖ´Ù.
    VDRL ¸é»ó ¹ÝÀÀ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
aging The gradual changes in the structure and function of humans and animals that occur with the passage of time, that do not result from disease or other gross accidents, and that eventually lead to the increased probability of death as the person or animal grows older. It does not apply to microorganisms.
(12 Dec 1998)
aging, premature Changes in the organism associated with senescence, occurring at an accelerated rate.
(12 Dec 1998)
cell aging The decrease in the cell's ability to proliferate with the passing of time. Each cell is programmed for a certain number of cell divisions and at the end of that time proliferation halts. The cell enters a quiescent state after which it experiences cell death via the process of apoptosis.
(12 Dec 1998)
clonal aging The deterioration in successive generations of a clone; thus paramecia and other simple forms, if allowed to reproduce asexually for a number of generations, invariably undergo deterioration, the characters of each group of descendants progressively departing from those of the original sexually produced ancestor.
(05 Mar 2000)
skin aging The process of aging due to changes in the structure and elasticity of the skin over time. It may be a part of physiological aging or it may be due to the effects of ultraviolet radiation, usually through exposure to sunlight.
(12 Dec 1998)
erythrocyte aging Senescence of the red blood cell. Lacking the organelles that make protein synthesis possible, the mature erythrocyte is incapable of self-repair, reproduction, and carrying out certain functions performed by other cells. This limits the average life span of an erythrocyte to 120 days.
(12 Dec 1998)
Venereal Disease Research Laboratory <microbiology> A blood test used to diagnose syphilis.
Read as nonreactive or negative if you do not have syphilis. The Venereal Disease Research Laboratory can also be positive is cases of leprosy, malaria, mononucleosis, lupus, hepatitis A and pregnancy.
Positive Venereal Disease Research Laboratory tests are usually followed up by a more specific test (FTA antibodies).
(12 Jan 1998)
Medical Research Council <organisation> A UK Government funded body to promote the balanced development of medical and related biological research in the United Kingdom.
It organises national clinical trials for the assessment of new treatment protocols for leukaemia and some of the related diseases.
(05 Jan 1998)
research Careful, a diligent search, a close searching, studious inquiry or examination.
(18 Nov 1997)
research, controlled The first controlled clinical research was probably done in 1875 by the british naval surgeon james lind who, on board the hms salisbury, gave sailors with scurvy either oranges or lemons or cider or vinegar or nutmeg (or another treatment) and after just six days discovered that the citrus-consuming sailors had recovered from scury, until then the scourge of extended sea voyages, while the sailors who had been given the other treatments remained uncured.
(12 Dec 1998)
research design A plan for collecting and utilizing data so that desired information can be obtained with sufficient precision or so that an hypothesis can be tested properly.
(12 Dec 1998)
research personnel Those individuals engaged in research.
(12 Dec 1998)
research support Financial support of research activities.
(12 Dec 1998)
peer review, research The evaluation by experts of the quality and pertinence of research or research proposals of other experts in the same field. Peer review is used by editors in deciding which submissions warrant publication, by granting agencies to determine which proposals should be funded, and by academic institutions in tenure decisions.
(12 Dec 1998)
clinical nursing research Research carried out by nurses in the clinical setting and designed to provide information that will help improve patient care. Other professional staff may also participate in the research.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aging
    ³ªÀ̸¦ ¸ÔÀ½
  • research
    ¿¬±¸
  • listener research
    Àαâ ÇÁ·ÎÁ¶»ç
  • market research
    (Á¦Ç°À» ¸ÅÃâÇϱâ ÀüÀÇ) ½ÃÀå Á¶»ç
  • market research
    ½ÃÀå Á¶»ç (¾î¶² »óǰÀÇ ¼ö¿ä¸¦ À§ÇÑ »çÀü Á¶»ç)
  • marketing research
    ½ÃÀå Á¶»ç;½ÃÀå ºÐ¼®
  • motivational research
    µ¿±â Á¶»ç
  • operations research
    ±â¾÷ °æ¿µ»óÀÇ °úÇÐÀû Á¶»ç ¿¬±¸;ÀÛÀü ¿¬±¸
  • research
    (Çмú)¿¬±¸;°úÇÐÀû ޱ¸;ÇмúÁ¶»ç;(½ÅÁßÇÑ)¼ö»ö;ޱ¸;Á¶»ç;¿¬±¸ ´É·Â;¿¬±¸½É;¿¬±¸ÇÏ´Ù;Á¶»çÇÏ´Ù;~able
  • research and development
    ¿¬±¸¿Í °³¹ß
  • research laboratory(institute)
    ¿¬±¸¼Ò
  • research library
    ¿¬±¸ µµ¼­°ü ´Â
  • research paper
    ¿¬±¸ ³í¹®;(ÇлýÀÇ)Çб⸻ ¸®Æ÷Æ®
  • research professor
    ¿¬±¸ ±³¼ö(´ëÇÐ µî¿¡¼­ ÀÚÀ¯·ÎÀÌ ¿¬±¸¿¡ ¸ôµÎÇÒ ¼ö ÀÖ´Â ±³¼ö)
  • research reactor
    ¿¬±¸¿ë ¿øÀÚ·Î
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á